Scientists ID Genes Affecting MS Patient Response To Copaxone
Oct 11th 2007Drug InformationGenetics
A group of Israeli scientists from the Technion Israel Institute of Technology, the Weizmann Institute of Science, and Teva Pharmaceutical Industries have recently identified genes responsible for the positive response of many multiple sclerosis (MS) patients to the drug CopaxoneŽ. These findings may contribute to the development of personalized medicine for MS sufferers.CopaxoneŽ was the first original Israeli drug to be approved by the U.S. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
